WARNING: This product is for research use only, not for human or veterinary use.
Hodoodo CAT#: H318963
CAS#: 28120-03-8 (hydrochloride)
Description: Tymazoline (trade name Thymazen in Poland) is a nasal decongestant that can be used to treat rhinitis. It acts as an antihistaminic and sympathomimetic, reducing swelling, inflammation and mucosal secretions.
Hodoodo Cat#: H318963
Name: Tymazoline HCl
CAS#: 28120-03-8 (hydrochloride)
Chemical Formula: C14H21ClN2O
Exact Mass: 0.00
Molecular Weight: 268.785
Elemental Analysis: C, 62.56; H, 7.88; Cl, 13.19; N, 10.42; O, 5.95
Related CAS #: 28120-03-8 (hydrochloride) 24243-97-8 (free base)
Synonym: D08658; Tymazoline HCl, trade name: Thymazen; Pernazene.
IUPAC/Chemical Name: 2-[(5-methyl-2-propan-2-ylphenoxy)methyl]-4,5-dihydro-1H-imidazole hydrochloride
InChi Key:
InChi Code:
SMILES Code: CC(C1=CC=C(C)C=C1OCC2=NCCN2)C.[H]Cl
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO, not in water
Shelf Life: >2 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
More Info:
Biological target: | |
In vitro activity: | |
In vivo activity: |
The following data is based on the product molecular weight 268.79 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
Formulation protocol: | |
In vitro protocol: | |
In vivo protocol: |
1: Antoniou CG, Markopoulou CK, Kouskoura MG, Koundourellis JE. Study and
development of reversed-phase HPLC systems for the determination of
2-imidazolines in the presence of preservatives in pharmaceutical preparations. J
AOAC Int. 2011 May-Jun;94(3):703-12. PubMed PMID: 21796997.
2: Levrier J, Molon-Noblot S, Duval D, Lloyd KG. A new ex vivo method for the
study of nasal drops on ciliary function. Fundam Clin Pharmacol.
1989;3(5):471-82. PubMed PMID: 2481638.